參考資料:
[1]Herman,M.A.,Metabolic liver disease—what’s in a name?Nature Reviews Endocrinology,2020.
[2]Jelena Todoric et al.(2020)Fructose stimulated de novo lipogenesis is promoted by inflammation. Nature Metabolism
[3]Giovanni Targher,et al.,(2021). Non-alcoholic fatty liver disease:a multisystem disease requiring a multidisciplinary and holistic approach. The Lancet Gastroenterology &;Hepatology
[4]非酒精性脂肪性肝病防治指南(2018更新版)[J].傳染病資訊,2018,31(05):393-402+420.
[5]Parthasarathy,G. et al."Pathogenesis of Nonalcoholic Steatohepatitis:An Overview."Hepatology Communications 4(2020):478 - 492.
[6]Younossi,Z. et al."Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates."Clinical Gastroenterology &;Hepatology 17(2019):748–755.e3.
[7]Younossi,Z. et al."Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis."Hepatology 69(2019):n. pag.
[8]Younossi,Z. et al."Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis:Implications for Liver Transplantation."Transplantation(2019):n. pag.
[9]Harrison,S. et al."NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis."Hepatology(Baltimore,Md.)71(2019):1198 - 1212.
[10]Choi,Hannah S. J. et al."Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B."Hepatology 71(2019):n. pag.
[11]Diehl,A. and Christopher Day."Cause,Pathogenesis,and Treatment of Nonalcoholic Steatohepatitis."The New England Journal of Medicine 377(2017):2063–2072.
[12]Kim,D. et al."Predictors of nonalcoholic steatohepatitis and significant fibrosis in non‐obese nonalcoholic fatty liver disease."Liver International 39(2019):332 - 341.
[13]Younossi,Z. et al."Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis."Hepatology 68(2018):n. pag.